NASDAQ: AZNAstraZeneca PLC

HealthcareMkt Cap $287.95BCongress ownership rank #399

AstraZeneca PLC Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 63 trades in AstraZeneca PLC (NASDAQ: AZN) since 2014, across 23 members, worth an estimated $1.6M in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 29 buys against 33 sells, a modestly sell-led skew, with Democratic members responsible for 37% of the trades and Republican members 63%. The most recent disclosure shown was filed April 2026, and Lisa Mcclain has filed the most AZN transactions among those shown, with 6. Other recent filers include Ro Khanna, Gilbert Cisneros, and Julia Letlow. One notable disclosed move was a purchase by Lisa Mcclain on July 22, 2025, up 27.3% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the AstraZeneca PLC (AZN) stock overview and the complete trade table below.